November 9-11, 2020 | Virtual Conference


Tao Bai, PhD

Lead Pharmacologist, Division of Bioequivalence I, Office of Bioequivalence (OB), OGD, CDER

Dr. Tao Bai is a Lead Pharmacologist and a Team Leader in Office of Bioequivalence (OB) in Office of Generic Drugs (OGD). In her current role, she coordinates all COVID-19 related scientific inquiries submitted to OGD and provide her professional input to ensure an efficient and consistent response to these inquiries in a timely fashion. Prior to joining FDA in 2010, Dr. Bai was a postdoctoral Research Fellow at University of Maryland School of Pharmacy studying Nasal and Inhalation Drug Products. She received her Ph.D. in Pharmaceutical Sciences from University of Maryland.

Skip to content